Menopause: Assessment and Hormonal Treatment
Image For Activity Cover
Expires on Dec 31, 2023
Credit Offered
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended
Menopause represents a hormonal imbalance that endocrinologists have the fundaments to screen and treat. The objectives of this Webinar are: to identify women in the menopause transition who are the best candidates for HT; to improve benefits and decrease risks through HT individualization, especially in women with previous endocrine conditions such as obesity, diabetes or PCOS; to reinforce that Testosterone is not part of menopause replacement therapy and should not be automatically prescribed.

  • The Menopausal Transition and The Moment to Replace Hormones presented by:

    Prof. Ruth Clapauch, MD,PhD, MSci

  • Managing Menopause: When We May Add Testosterone presented by:

    Prof. Susan Ruth Davis, FRACP,PhD,MBBS,FAHMS 

  • Underlying Risk of Breast Cancer and Cardiovascular Disease Role in determining personalized risk and benefit of MHT presented by:

    Prof. Richard Santen, MD

The intended audience for this activity includes a wide range of health care providers; many may deem this presentation beneficial.

At the conclusion of this presentation, the audience will:

  1. Understand the acute and long-term effects of hypoestrogenism.
  2. Acknowledge the metabolic and cardiovascular differences between current hormones used as therapy.
  3. Understand when to measure blood testosterone in postmenopausal women.
  4. Be aware of the indication for treatment of postmenopausal women with testosterone.
  5. Understand the concepts and application of the term personalized medicine when advising menopausal patients about treatment.
  6. Learn how important underlying risk is when considering the effect of menopausal hormone therapy on breast cancer risk.
  7. Understand the step by step approach needed to manage menopausal symptoms.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at


  • Prof. Ruth Clapauch, MD,PhD, MSciRio de Janeiro State University 
  • Prof. Susan Ruth Davis, FRACP,PhD,MBBS,FAHMS 
    NHMRC Senior Principal Research Fellow; Director, Monash University Women’s Health Research Program 
  • Prof. Richard Santen, MD
    University of Virginia 

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported no relevant financial relationships.

The Endocrine Society staff report no relevant financial relationships.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By